The six disease of WHO.
作者信息
Waters M F
出版信息
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1320-2. doi: 10.1136/bmj.283.6302.1320.
Abstract
摘要
相似文献
1
The six disease of WHO.世界卫生组织的六种疾病。
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1320-2. doi: 10.1136/bmj.283.6302.1320.
2
The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.利福平与氨苯砜对实验性麻风分枝杆菌感染的作用：最低抑菌浓度及杀菌作用
J Med Microbiol. 1972 May;5(2):251-61. doi: 10.1099/00222615-5-2-251.
3
Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.2010-2012 年美国美属萨摩亚的麻风病患者中出现氨苯砜耐药。
Emerg Infect Dis. 2018 Aug;24(8):1584-1585. doi: 10.3201/eid2408.180033.
4
[Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].[马提尼克岛麻风杆菌对氨苯砜和利福平耐药性的建立动态]
Acta Leprol. 1986 Jul-Sep;4(3):293-300.
5
The diagnosis and management of dapsone-resistant leprosy.耐氨苯砜麻风病的诊断与管理
Lepr Rev. 1977 Jun;48(2):95-105. doi: 10.5935/0305-7518.19770011.
6
Dapsone drug resistance in the MDT era.多药联合治疗时代的氨苯砜耐药性。
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5.
7
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.克拉霉素对耐氨苯砜和利福平以及对氨苯砜和利福平敏感的麻风分枝杆菌菌株具有杀菌作用。
Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):59-65.
8
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.利福平对耐氨苯砜麻风病的长期治疗：临床与细菌学研究
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):159-69.
9
Mycobacterium leprae persisters after treatment with dapsone and rifampicin.麻风分枝杆菌在用氨苯砜和利福平治疗后仍有持留菌。
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):154-8.
10
Correlation of laboratory and clinical data during treatment of leprosy.麻风病治疗期间实验室数据与临床数据的相关性
Ann Soc Belg Med Trop. 1972;52(6):537-48.
引用本文的文献
1
SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白激活跨膜蛋白16F（TMEM16F）介导的血小板促凝活性。
Front Cardiovasc Med. 2023 Jan 4;9:1013262. doi: 10.3389/fcvm.2022.1013262. eCollection 2022.
2
LNC942 promoting METTL14-mediated mA methylation in breast cancer cell proliferation and progression.LNC942 促进乳腺癌细胞增殖和进展中的 METTL14 介导的 mA 甲基化。
Oncogene. 2020 Jul;39(31):5358-5372. doi: 10.1038/s41388-020-1338-9. Epub 2020 Jun 23.
本文引用的文献
1
A classification of leprosy for research purposes.用于研究目的的麻风病分类。
Lepr Rev. 1962 Apr;33:119-28. doi: 10.5935/0305-7518.19620014.
2
Acid-fast bacilli in nasal excretions in leprosy, and results of inoculation of mice.麻风病患者鼻分泌物中的抗酸杆菌及小鼠接种结果。
Am J Hyg. 1960 Mar;71:147-57. doi: 10.1093/oxfordjournals.aje.a120098.
3
SULPHONE RESISTANCE IN LEPROSY. AN EXPERIMENTAL AND CLINICAL STUDY.麻风病中的砜类耐药性。一项实验与临床研究。
Lancet. 1964 Sep 26;2(7361):673-4. doi: 10.1016/s0140-6736(64)92482-1.
4
Classification of leprosy according to immunity. A five-group system.根据免疫情况对麻风病进行分类。一种五组分类系统。
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73.
5
Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo.将犰狳（九带犰狳，Dasypus novemcinctus Linn.）确立为麻风病研究模型的尝试。一、关于一只实验感染犰狳发生瘤型麻风病的报告。
Int J Lepr Other Mycobact Dis. 1971 Jul-Sep;39(3):693-702.
6
7
Experimental and clinical studies on rifampicin in treatment of leprosy.利福平治疗麻风病的实验与临床研究
Br Med J. 1970 Jan 10;1(5688):89-92. doi: 10.1136/bmj.1.5688.89.
8
The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients.麻风分枝杆菌在使用4,4'-二氨基二苯砜（DDS）治疗期间的死亡情况。患者的初始速率。
Am J Trop Med Hyg. 1968 Sep;17(5):769-75. doi: 10.4269/ajtmh.1968.17.769.
9
Experimental lepromatous leprosy.实验性瘤型麻风
Nature. 1967 Aug 5;215(5101):599-602. doi: 10.1038/215599a0.
10
Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.氨苯砜治疗瘤型麻风十年：临床、细菌学和组织学评估以及活麻风杆菌的发现
Lepr Rev. 1974 Dec;45(4):288-98. doi: 10.5935/0305-7518.19740034.
Zotero 插件